Achieve Life Sciences Announces Participation at Fall Investor Conferences Sep 7, 2022 08:00AM
Achieve Life Sciences Announces Participation at Fall Investor Conferences Sep 7, 2022 08:00AM
Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020 Oct 27, 2020 05:30AM
Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option Dec 19, 2019 04:05PM
Achieve Life Sciences (ACHV) Pricing Offering at $0.60/Unit Dec 17, 2019 01:08PM


Dec 17, 2019 01:06PM Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
Nov 6, 2019 06:30AM Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program
Sep 5, 2019 05:30AM Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial
Sep 4, 2019 05:30AM Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences
Jun 11, 2019 11:26AM UPDATE: Achieve Life Sciences (ACHV) PT Raised to $20 at Ladenburg Thalmann
Oct 1, 2018 09:07AM Achieve Life Sciences (ACHV) Prices $5.6 Million Registered Direct Offering of Common Stock, Warrants
Oct 1, 2018 09:05AM Achieve Announces Pricing of $5.6 Million Registered Direct Offering
Sep 27, 2018 12:54PM Achieve Life Sciences (ACHV) Bullish View Reiterated at Ladenburg Thalmann
Sep 26, 2018 05:30AM Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018
Aug 20, 2018 06:45AM Ladenburg Thalmann Starts Achieve Life Sciences (ACHV) at Buy
Jun 19, 2018 04:01PM Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Jun 15, 2018 08:32AM Achieve Life Sciences (ACHV) Prices $12M Public Offering
Jun 15, 2018 08:30AM Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering